GlycoNex (ROCO:4168) Other Stockholders Equity : NT$-7.91 Mil (As of Mar. 2024)

View and export this data going back to 2012. Start your Free Trial

What is GlycoNex Other Stockholders Equity?

GlycoNex's Other Stockholders Equity for the quarter that ended in Mar. 2024 was NT$-7.91 Mil.

GlycoNex's quarterly Other Stockholders Equity declined from Sep. 2023 (NT$-5.89 Mil) to Dec. 2023 (NT$-6.73 Mil) and declined from Dec. 2023 (NT$-6.73 Mil) to Mar. 2024 (NT$-7.91 Mil).

GlycoNex's annual Other Stockholders Equity increased from Dec. 2021 (NT$-6.87 Mil) to Dec. 2022 (NT$-5.83 Mil) but then declined from Dec. 2022 (NT$-5.83 Mil) to Dec. 2023 (NT$-6.73 Mil).

GlycoNex Other Stockholders Equity Historical Data

The historical data trend for GlycoNex's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GlycoNex Other Stockholders Equity Chart

GlycoNex Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Stockholders Equity

Get a 7-Day Free Trial

-5.74

0.42

-6.87

-5.83

-6.73

GlycoNex Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Stockholders Equity	Get a 7-Day Free Trial															-4.57	-5.06	-5.89	-6.73	-7.91

GlycoNex Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

GlycoNex Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of GlycoNex's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

GlycoNex (ROCO:4168) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GlycoNex Inc (ROCO:4168) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Section 1, Xintai 5th Road, 8th Floor, No. 97, Xizhi District, New Taipei City, TWN, 221

Website

http://www.glyconex.com.tw

GlycoNex Inc is a Taiwan based company engaged in the development of cancer drugs from the combination of glycosphingolipid antigen and human monoclonal antibody technologies. It has a panel of antibodies which targets various carbohydrate antigens. The antibodies are cloned from hybridoma, engineered to improve stability and can serve as reagent with applications that include ELISA, Western blot, flow cytometry, TLC immunostaining, and IHC. The group also provides antibody research service to its academic and industrial clients. The other services provided by the firm include functional evaluation, antibody engineering, and antibody characterization.

GlycoNex (ROCO:4168) Headlines

No Headlines